title: Effect of Cornell product and other ECG left ventricular hypertrophy criteria on various cardiovascular endpoints in type 2 diabetic patients.
authors.affiliation: CHU de Poitiers, Cardiologie, Poitiers, France; Université de Poitiers, Laboratoire MOVE (EA 6314), Poitiers, France. Electronic address: philippe.sosner@univ-poitiers.fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Sosner
authors.affiliation: CHU de Poitiers, Réanimation Médicale, Poitiers, France.
authors.forename: Séverin
authors.initials: S
authors.lastname: Cabasson
authors.affiliation: CHU de Poitiers, Physiologie, France; Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Hulin-Delmotte
authors.affiliation: Université de Poitiers, CIC1402, Poitiers, France; CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France; Inserm, CIC1402, Poitiers, France.
authors.forename: Pierre-Jean
authors.initials: PJ
authors.lastname: Saulnier
authors.affiliation: CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Elise
authors.initials: E
authors.lastname: Gand
authors.affiliation: CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Florence
authors.initials: F
authors.lastname: Torremocha
authors.affiliation: CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Piguel
authors.affiliation: Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France; CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Miot
authors.affiliation: Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France; CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Maréchaud
authors.affiliation: CHU de Poitiers, Cardiologie, Poitiers, France; Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France.
authors.forename: Daniel
authors.initials: D
authors.lastname: Herpin
authors.affiliation: Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France; Université de Poitiers, CIC1402, Poitiers, France; CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France; Inserm, CIC1402, Poitiers, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Ragot
authors.affiliation: Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers, France; Université de Poitiers, CIC1402, Poitiers, France; CHU de Poitiers, Centre d'Investigation Clinique, Poitiers, France; Inserm, CIC1402, Poitiers, France; CHU de Poitiers, Endocrinologie, Poitiers, France.
authors.forename: Samy
authors.initials: S
authors.lastname: Hadjadj
mesh_terms: D000368:Aged; D015331:Cohort Studies; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology*; D004562:Electrocardiography / Q000295:instrumentation / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016896:Treatment Outcome
keywords: Cardiac damage; Cardiovascular outcomes; Diabetes; Left ventricular hypertrophy